Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Dunn, Barnaby D.
2012.
Helping Depressed Clients Reconnect to Positive Emotion Experience: Current Insights and Future Directions.
Clinical Psychology & Psychotherapy,
Vol. 19,
Issue. 4,
p.
326.
Uher, Rudolf
and
Rutter, Michael
2012.
Basing psychiatric classification on scientific foundation: Problems and prospects.
International Review of Psychiatry,
Vol. 24,
Issue. 6,
p.
591.
Uher, Rudolf
Tansey, Katherine E
Malki, Karim
and
Perlis, Roy H
2012.
Biomarkers predicting treatment outcome in depression: what is clinically significant?.
Pharmacogenomics,
Vol. 13,
Issue. 2,
p.
233.
Uher, Rudolf
Perlis, Roy H.
Placentino, Anna
Dernovšek, Mojca Zvezdana
Henigsberg, Neven
Mors, Ole
Maier, Wolfgang
McGuffin, Peter
and
Farmer, Anne
2012.
SELF-REPORT AND CLINICIAN-RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER?.
Depression and Anxiety,
Vol. 29,
Issue. 12,
p.
1043.
Baldessarini, Ross J.
2013.
Chemotherapy in Psychiatry.
p.
155.
Rizvi, Sakina J.
Salomons, Tim V.
Konarski, Jakub Z.
Downar, Jonathan
Giacobbe, Peter
McIntyre, Roger S.
and
Kennedy, Sidney H.
2013.
Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation.
Journal of Affective Disorders,
Vol. 151,
Issue. 2,
p.
573.
Rizvi, Sakina J.
Salomons, Tim V.
Konarski, Jakub Z.
Downar, Jonathan
Giacobbe, Peter
McIntyre, Roger S.
and
Kennedy, Sidney H.
2013.
WITHDRAWN: Neural response to emotional stimuli associated with successful antidepressant treatment and behavioural activation.
Journal of Affective Disorders,
Argyropoulos, Spilios V
and
Nutt, David J
2013.
Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?.
Journal of Psychopharmacology,
Vol. 27,
Issue. 10,
p.
869.
Clayton, Anita H
Baker, Ross A
Sheehan, John J
Cain, Zachary J
Forbes, Robert A
Marler, Sabrina Vogel
Marcus, Ronald
Berman, Robert M
and
Thase, Michael E
2014.
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
BMC Research Notes,
Vol. 7,
Issue. 1,
Pizzagalli, Diego A.
2014.
Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model.
Annual Review of Clinical Psychology,
Vol. 10,
Issue. 1,
p.
393.
van Os, Jim
Delespaul, Philippe
Barge, Daniela
Bakker, Roberto P.
and
Fang, Yiru
2014.
Testing an mHealth Momentary Assessment Routine Outcome Monitoring Application: A Focus on Restoration of Daily Life Positive Mood States.
PLoS ONE,
Vol. 9,
Issue. 12,
p.
e115254.
Calabrese, Joseph R.
Fava, Maurizio
Garibaldi, George
Grunze, Heinz
Krystal, Andrew D.
Laughren, Thomas
Macfadden, Wayne
Marin, Robert
Nierenberg, Andrew A.
and
Tohen, Mauricio
2014.
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
Journal of Affective Disorders,
Vol. 168,
Issue. ,
p.
439.
Lally, N
Nugent, A C
Luckenbaugh, D A
Ameli, R
Roiser, J P
and
Zarate, C A
2014.
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
Translational Psychiatry,
Vol. 4,
Issue. 10,
p.
e469.
Uher, Rudolf
Payne, Jennifer L.
Pavlova, Barbara
and
Perlis, Roy H.
2014.
MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV.
Depression and Anxiety,
Vol. 31,
Issue. 6,
p.
459.
Lane, Roger M
2014.
Restoration of positive mood states in major depression as a potential drug development target.
Journal of Psychopharmacology,
Vol. 28,
Issue. 6,
p.
527.
Perlis, Roy H
2014.
Pharmacogenomic Testing and Personalized Treatment of Depression.
Clinical Chemistry,
Vol. 60,
Issue. 1,
p.
53.
Schacht, Alexander
Gorwood, Philip
Boyce, Philip
Schaffer, Ayal
and
Picard, Hernan
2014.
Depression symptom clusters and their predictive value for treatment outcomes: Results from an individual patient data meta-analysis of duloxetine trials.
Journal of Psychiatric Research,
Vol. 53,
Issue. ,
p.
54.
Lally, Níall
Nugent, Allison C
Luckenbaugh, David A
Niciu, Mark J
Roiser, Jonathan P
and
Zarate, Carlos A
2015.
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
Journal of Psychopharmacology,
Vol. 29,
Issue. 5,
p.
596.
Fried, Eiko I
and
Nesse, Randolph M
2015.
Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential.
BMC Medicine,
Vol. 13,
Issue. 1,
Park, Seon-Cheol
Lee, Min-Soo
Shinfuku, Naotaka
Sartorius, Norman
and
Park, Yong Chon
2015.
Gender differences in depressive symptom profiles and patterns of psychotropic drug usage in Asian patients with depression: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants study.
Australian & New Zealand Journal of Psychiatry,
Vol. 49,
Issue. 9,
p.
833.